Updated on 18 Nov 2026, 04:52 PM IST
|
| ||||
|
| ||||
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,872.30 | 0.12 | 4,49,216.90 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 11,070.00 | -0.41 | 2,93,873.71 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,637.95 | -0.71 | 1,76,406.40 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,420.00 | 2.68 | 1,14,715.89 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,195.00 | -0.64 | 1,19,201.71 | 21.19 | 4.24 | 0.09 | 14.22 |
| Meeting Date | Purpose |
|---|---|
| 2026-11-13 | Quarterly Results |
| 2026-10-07 | Proposal of fund raising |
| 2026-08-14 | Quarterly Results |
| 2026-08-12 | Proposal Of Fund Raising |
| 2026-05-19 | Audited Results |
Dishman Carbogen Amcis is trading at 121.25 as on Wed Nov 18 2026 10:29:30. This is -6.80% lower as compared to its previous closing price of 130.10.
The market capitalization of Dishman Carbogen Amcis is 1901.00 Cr as on Wed Nov 18 2026 10:29:30.
The 52 wk high for Dishman Carbogen Amcis is 274.20 whereas the 52 wk low is 128.25
Dishman Carbogen Amcis can be analyzed on the following key metrics -
Dishman Carbogen Amcis reported a net profit of 97.45 Cr in 2026.
The Mutual Fund Shareholding was 1.41% at the end of 30 Sep 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.